Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for arthritis--where do we stand?

Yuti Chernajovsky1

  • 1William Harvey Research Institute, Barts and The London, Queen Mary's School of Medicine and Dentistry, University of London, London, UK. y.chernajovsky@qmul.ac.uk

Arthritis Research & Therapy
|November 10, 2005
PubMed
Summary

Gene therapy offers a potential alternative to biologicals for treating inflammatory arthritis. Demonstrating superior therapeutic and safety benefits, alongside economic feasibility and global accessibility, is crucial for its adoption.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune-mediated inflammation across disease boundaries: breaking down research silos.

Nature immunology·2021
Same author

Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscle.

Current gene therapy·2014
Same author

Growth associated protein (GAP-43): cloning and the development of a sensitive ELISA for neurological disorders.

Journal of neuroimmunology·2014
Same author

Latent cytokines for targeted therapy of inflammatory disorders.

Expert opinion on drug delivery·2013
Same author

Latency can be conferred to a variety of cytokines by fusion with latency-associated peptide from TGF-β.

Expert opinion on drug delivery·2013
Same author

Generation of an efficiently secreted, cell penetrating NF-κB inhibitor.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2013

Area of Science:

  • Rheumatology
  • Gene Therapy
  • Immunology

Background:

  • Biological therapies have significantly improved rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis management.
  • Current treatments, while effective, present ongoing challenges in long-term efficacy and patient-specific responses.

Purpose of the Study:

  • To explore gene therapy as a novel treatment modality for inflammatory arthropathies.
  • To outline the critical benchmarks for gene therapy's successful integration into arthritis care, focusing on patient benefit and accessibility.

Main Methods:

  • This study reviews existing literature on biologicals and emerging gene therapy research for arthritis.
  • It analyzes the therapeutic and safety profiles required for a new treatment modality.
  • Economic feasibility and global access considerations are assessed.

Related Experiment Videos

Main Results:

  • Biologicals have transformed arthritis treatment, but challenges remain.
  • Gene therapy development must prioritize enhanced therapeutic outcomes and safety over current standards.
  • Economic viability and worldwide patient accessibility are key determinants for clinical success.

Conclusions:

  • Gene therapy holds promise for treating rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis.
  • Demonstrating clear advantages in therapy, safety, cost-effectiveness, and accessibility is essential for gene therapy adoption in rheumatology.
  • Further research and development are needed to overcome current challenges.